Twelve-month medication persistence in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

摘要

AimsThis study aimed to assess patients' baseline characteristics and provider factors influencing the continuation of medication for 12months in patients who were newly diagnosed with benign prostatic hyperplasia (BPH).